Inside Drug Pricing - 08/12/2019

Drug Import Realities Kick In; Politics Drove CAR-T Coverage; Novartis In Hot Seat

By John Wilkerson
August 12, 2019 at 11:23 AM
Drug pricing continues to dominate the health policy arena with a whirlwind of news spanning drug importation, cancer drug coverage and clinical trial data manipulation. A week after HHS announced a drug import initiative, the reality of how difficult it will be to execute that plan began to set in. Hospitals and oncologists scored a win on CAR-T coverage days after suffering a partial loss on Medicare payment for the pricey cancer drug. And the maker of the world’s most...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.